Radicava (edravone) injection and Radicava ORS, an oral suspension, are used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurodegenerative disease, which affects nerve cells in the spinal cord and brain.
| Brand Name: | RADICAVA |
| Generic Name: | edaravone |
| Strength: | • Injection: 30 mg/100 mL in a single-dose polypropylene bag • Oral suspension: 105 mg/5 mL in a multi-dose amber glass bottle |
| Manufacturer: | Mitsubishi Tanabe Pharma |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
